Cancer Care In The COVID-19 Era: Exact Sciences Touts Data For Oncotype Dx Breast Test

11 Jun 2020

• By Catherine Longworth

As hospitals struggle to prioritize care during the pandemic, molecular and genomic tests are proving helpful in distinguishing patients eligible for neoadjuvant therapy whilst surgical capacity is limited.

Cancer cells on scientific background.3d illustration

With hospitals facing significant challenges in delivering care during the COVID-19 outbreak, cancer patients have been some of the most impacted by the pandemic.

As physicians look for ways to prioritize care, they are increasingly relying on genomic and molecular testing to help them...